表紙
市場調查報告書
商品編碼
1017554

全球乳房活檢市場(核心針、真空輔助、細針穿刺活檢):洞察和預測,包括 COVID-19 的潛在影響(2021-2025)

Global Breast Biopsy Market (Core Needle, Vacuum Assisted & Fine Needle Aspiration): Insights & Forecast with Potential Impact of COVID-19 (2021-2025)

出版日期: | 出版商: Koncept Analytics | 英文 101 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球乳腺活檢市場預計在 2021 年至 2025 年間以 8.68% 的複合年增長率增長,到 2025 年將達到 16.6 億美元。全球乳房活檢市場的增長受到乳腺癌患病率上升和 65 歲以上女性人口不斷增長等因素的支持。液體活檢的持續引入也可能對全球乳房活檢市場產生積極影響。然而,由於與進行乳房活檢相關的感染可能性增加,預計市場增長將受到限制。

全球乳房活檢市場可分為三個部分:空心針活檢 (CNB)、真空輔助活檢 (VAB) 和細針穿刺活檢 (FNAB)。在2020年的全球乳腺活檢市場中,核心針活檢(CNB)將佔據壓倒性的份額,其次是真空輔助活檢(VAB)。圖像引導的乳房活檢的全球市場分為乳房 X 線照相引導的立體定向活檢、超聲引導的活檢、MRI 引導的活檢和 CT 引導的活檢。乳房 X 線立體定向活檢的份額最高,其次是超聲引導活檢和 MRI 引導活檢。

本報告調查了全球乳房活檢市場,並概述了乳房活檢以及 COVID-19 的影響、區域趨勢和進入市場的公司概況。

目錄

第 1 章市場概覽

  • 乳房活檢
    • 乳腺活檢-介紹
    • 乳房活檢的準備
    • 乳房活檢結果
    • 與乳房活檢相關的風險
  • 乳房活檢類型
    • 細針抽吸
    • 空心針活檢
    • 真空輔助乳房活檢
    • 直接和額葉活檢
    • 切除(手術)活檢

第 2 章 COVID-19 的影響

  • COVID-19 對乳房活檢市場的影響
  • COVID-19 對乳腺活檢患者群體的影響

第三章市場分析

  • 全球乳腺活檢市場
  • 全球乳腺活檢市場預測
  • 按類型劃分的全球乳腺活檢市場
    • 全球核心針穿刺活檢 (CNB) 市場
    • 全球核心針刺活檢 (CNB) 市場預測
    • 全球真空輔助活檢 (VAB) 市場
    • 全球真空輔助活檢 (VAB) 市場預測
    • 全球細針穿刺活檢 (FNAB) 市場
    • 全球細針穿刺活檢 (FNAB) 市場預測
  • 圖像引導技術的全球乳腺活檢市場
    • 全球乳房 X 光引導立體定向乳房活檢市場
    • 全球乳房 X 光引導立體定向乳房活檢市場預測
    • 全球超聲引導乳房活檢市場
    • 全球超聲引導乳房活檢市場預測
    • 全球 MRI 引導的乳腺活檢市場
    • 全球 MRI 引導的乳腺活檢市場預測
    • 全球 CT 引導的乳腺活檢市場
    • 全球 CT 指南乳房活檢市場預測
  • 按地區劃分的全球乳腺活檢市場

第 4 章區域市場

  • 北美
    • 北美乳房活檢市場
    • 北美乳腺活檢市場預測
  • 歐洲
    • 歐洲乳房活檢市場
    • 歐洲乳房活檢市場預測
    • 歐洲乳房活檢市場
    • 歐洲乳房活檢市場價值預測
  • 亞太地區
    • 亞太乳房活檢市場
    • 亞太乳房活檢市場預測
    • 亞太乳房活檢市場
    • 亞太地區乳腺活檢市場價值預測
  • 其他領域
    • 其他地區乳房活檢市場的價值
    • 預測其他地區乳房活檢市場的價值

第 5 章市場動態

  • 增長因素
    • 乳腺癌患病率增加
    • 老年婦女人口增加
    • 納入微創乳房活檢
    • 乳腺癌識別倡議的興起
  • 主要趨勢和發展
    • 液體活檢的勢頭越來越大
  • 挑戰
    • 感染風險
    • 缺乏新興國家的醫療保健基礎設施

第6章競爭形勢

  • 世界市場
    • 收入比較 - 主要參與者
    • 市值比較 - 主要參與者
    • 研發費用比較-關鍵玩家

第 7 章公司簡介

  • Hologic
  • Danaher Corporation
  • Becton, Dickinson & Company
  • Roche Group
  • Medtronic
  • Qiagen
目錄

The global breast biopsy market is forecasted to reach US$1.66 billion in 2025, experiencing growth at a CAGR of 8.68% during the period spanning from 2021 to 2025. Growth in the global breast biopsy market was supported by factors such as increasing prevalence of breast cancer and rising female population aged 65 or above. Growing adoption of liquid biopsy is likely to have a positive impact on the global breast biopsy market. However, the market growth is expected to be restrained by increasing possibility of infection associated with breast biopsy procedure.

The global breast biopsy market by type can be segmented into the following segments: core needle biopsy (CNB), vacuum assisted biopsy (VAB) and fine needle aspiration biopsy (FNAB). In 2020, the dominant share of global breast biopsy market was held by core needle biopsy (CNB), followed by vacuum assisted biopsy (VAB). The global breast biopsy market by image guided technology can be segmented as follows: mammography guided stereotactic biopsy, ultrasound guided biopsy, MRI guided biopsy and CT guided biopsy. The largest share of the market was held by mammography guided stereotactic biopsy, followed by ultrasound guided biopsy and MRI guided biopsy.

The global breast biopsy market by region can be segmented into the following segments: North America, Europe and Asia Pacific. In 2020, the dominant share of market was held by North America, followed by Europe and Asia Pacific. Factors such as rising elderly female population, growing awareness regarding early detection of breast cancer and increasing income of the consumers helped in boosting market growth.

Scope of the report:

  • The report provides a comprehensive analysis of the global breast biopsy market with potential impact of COVID-19.
  • The major regional markets (North America, Europe and Asia Pacific) have been analyzed.
  • The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
  • The competitive landscape of the market, along with the company profiles of leading players (Hologic, Danaher Corporation, Becton, Dickinson & Company, Roche Group, Medtronic and Qiagen) are also presented in detail.

Key Target Audience:

  • Breast Biopsy Manufacturers
  • Raw Material Providers
  • End Users (Businesses/Consumers)
  • Investment Banks
  • Government Bodies & Regulating Authorities

Table of Contents

1. Market Overview

  • 1.1 Breast Biopsy
    • 1.1.1 Breast Biopsy - Introduction
    • 1.1.2 Preparation of a Breast Biopsy
    • 1.1.3 Results of a Breast Biopsy
    • 1.1.4 Risks Associated with Breast Biopsy
  • 1.2 Types of Breast Biopsies
    • 1.2.1 Fine Needle Aspiration
    • 1.2.2 Core Needle Biopsy
    • 1.2.3 Vacuum Assisted Breast Biopsy
    • 1.2.4 Direct & Frontal Biopsy
    • 1.2.5 Excisional (Surgical) Biopsy

2. Impact of COVID-19

  • 2.1 Impact of COVID-19 on Breast Biopsy Market
  • 2.2 Impact of COVID-19 on Breast Biopsy Patient Population

3. Market Analysis

  • 3.1 Global Breast Biopsy Market by Value
  • 3.2 Global Breast Biopsy Market Forecast by Value
  • 3.3 Global Breast Biopsy Market by Type
    • 3.3.1 Global Core Needle Biopsy (CNB) Market by Value
    • 3.3.2 Global Core Needle Biopsy (CNB) Market Forecast by Value
    • 3.3.3 Global Vacuum Assisted Biopsy (VAB) Market by Value
    • 3.3.4 Global Vacuum Assisted Biopsy (VAB) Market Forecast by Value
    • 3.3.5 Global Fine Needle Aspiration Biopsy (FNAB) Market by Value
    • 3.3.6 Global Fine Needle Aspiration Biopsy (FNAB) Market Forecast by Value
  • 3.4 Global Breast Biopsy Market by Image Guided Technology
    • 3.4.1 Global Mammography Guided Stereotactic Breast Biopsy Market by Value
    • 3.4.2 Global Mammography Guided Stereotactic Breast Biopsy Market Forecast by Value
    • 3.4.3 Global Ultrasound Guided Breast Biopsy Market by Value
    • 3.4.4 Global Ultrasound Guided Breast Biopsy Market Forecast by Value
    • 3.4.5 Global MRI Guided Breast Biopsy Market by Value
    • 3.4.6 Global MRI Guided Breast Biopsy Market Forecast by Value
    • 3.4.7 Global CT Guided Breast Biopsy Market by Value
    • 3.4.8 Global CT Guided Breast Biopsy Market Forecast by Value
  • 3.5 Global Breast Biopsy Market by Region

4. Regional Market

  • 4.1 North America
    • 4.1.1 North America Breast Biopsy Market by Value
    • 4.1.2 North America Breast Biopsy Market Forecast by Value
  • 4.2 Europe
    • 4.2.1 Europe Breast Biopsy Market by Value
    • 4.2.2 Europe Breast Biopsy Market Forecast by Value
    • 4.2.3 Europe Breast Biopsy Market by Type
    • 4.2.4 Europe Breast Biopsy Market Value Forecast by Type
  • 4.3 Asia Pacific
    • 4.3.1 Asia Pacific Breast Biopsy Market by Value
    • 4.3.2 Asia Pacific Breast Biopsy Market Forecast by Value
    • 4.3.3 Asia Pacific Breast Biopsy Market by Type
    • 4.3.4 Asia Pacific Breast Biopsy Market Value Forecast by Type
  • 4.4 ROW
    • 4.4.1 ROW Breast Biopsy Market by Value
    • 4.4.2 ROW Breast Biopsy Market Forecast by Value

5. Market Dynamics

  • 5.1 Growth Drivers
    • 5.1.1 Rising Prevalence of Breast Cancer
    • 5.1.2 Increase in Aged Female Population
    • 5.1.3 Incorporation of Minimally Invasive Breast Biopsies
    • 5.1.4 Rise in Initiatives Regarding Awareness of Breast Cancer
  • 5.2 Key Trends & Developments
    • 5.2.1 Rising Momentum of Liquid Biopsy
  • 5.3 Challenges
    • 5.3.1 Risk of Infections
    • 5.3.2 Lack of Healthcare Infrastructure in Developing Countries

6. Competitive Landscape

  • 6.1 Global Market
    • 6.1.1 Revenue Comparison- Key Players
    • 6.1.2 Market Capitalization Comparison- Key Players
    • 6.1.3 Research & Development Expenses Comparison- Key Players

7. Company Profiles

  • 7.1 Hologic
    • 7.1.1 Business Overview
    • 7.1.2 Financial Overview
    • 7.1.3 Business Strategies
  • 7.2 Danaher Corporation
    • 7.2.1 Business Overview
    • 7.2.2 Financial Overview
    • 7.2.3 Business Strategies
  • 7.3 Becton, Dickinson & Company
    • 7.3.1 Business Overview
    • 7.3.2 Financial Overview
    • 7.3.3 Business Strategies
  • 7.4 Roche Group
    • 7.4.1 Business Overview
    • 7.4.2 Financial Overview
    • 7.4.3 Business Strategies
  • 7.5 Medtronic
    • 7.5.1 Business Overview
    • 7.5.2 Financial Overview
    • 7.5.3 Business Strategies
  • 7.6 Qiagen
    • 7.6.1 Business Overview
    • 7.6.2 Financial Overview
    • 7.6.3 Business Strategies

List of Charts

  • Global Breast Biopsy Market by Value (2016-2020)
  • Global Breast Biopsy Market Forecast by Value (2021-2025)
  • Global Breast Biopsy Market by Type (2020)
  • Global Core Needle Biopsy (CNB) Market by Value (2016-2020)
  • Global Core Needle Biopsy (CNB) Market Forecast by Value (2021-2025)
  • Global Vacuum Assisted Biopsy (VAB) Market by Value (2016-2020)
  • Global Vacuum Assisted Biopsy (VAB) Market Forecast by Value (2021-2025)
  • Global Fine Needle Aspiration (FNAB) Market by Value (2016-2020)
  • Global Fine Needle Aspiration (FNAB) Market Forecast by Value (2021-2025)
  • Global Breast Biopsy Market by Image Guided Technology (2020)
  • Global Mammography Guided Stereotactic Breast Biopsy Market by Value (2016-2020)
  • Global Mammography Guided Stereotactic Breast Biopsy Market Forecast by Value (2019-2024)
  • Global Ultrasound Guided Breast Biopsy Market by Value (2016-2020)
  • Global Ultrasound Guided Breast Biopsy Market Forecast by Value (2019-2024)
  • Global MRI Guided Breast Biopsy Market by Value (2016-2020)
  • Global MRI Guided Breast Biopsy Market Forecast by Value (2021-2025)
  • Global CT Guided Breast Biopsy Market by Value (2016-2020)
  • Global CT Guided Breast Biopsy Market Forecast by Value (2021-2025)
  • Global Breast Biopsy Market by Region (2020)
  • North America Breast Biopsy Market by Value (2016-2020)
  • North America Breast Biopsy Market Forecast by Value (2021-2025)
  • Europe Breast Biopsy Market by Value (2016-2020)
  • Europe Breast Biopsy Market Forecast by Value (2021-2025)
  • Europe Breast Biopsy Market by Type (2020)
  • Europe Breast Biopsy Market Value Forecast by Type (2020-2025)
  • Asia Pacific Breast Biopsy Market by Value (2016-2020)
  • Asia Pacific Breast Biopsy Market Forecast by Value (2021-2025)
  • Asia Pacific Breast Biopsy Market by Type (2020)
  • Asia Pacific Breast Biopsy Market Value Forecast by Type (2020-2025)
  • ROW Breast Biopsy Market by Value (2016-2020)
  • ROW Breast Biopsy Market Forecast by Value (2021-2025)
  • Global Prevalence of Breast Cancer (2014-2020)
  • Global Female Population (Aged 65 & Above) (2015-2020)
  • Hologic Total Revenue & Net Income (Loss) (2016-2020)
  • Hologic Total Revenue by Segment (2020)
  • Hologic Total Revenue by Region (2020)
  • Danaher Corporation Sales and Net Earnings (2016-2020)
  • Danaher Corporation Sales by Segment (2020)
  • Danaher Corporation Sales by Region (2020)
  • Becton, Dickinson & Company Revenue and Net Income (2016-2020)
  • Becton, Dickinson & Company Revenue by Segment (2020)
  • Becton, Dickinson & Company Revenue by Region (2020)
  • Roche Group Sales and Net Income (2016-2020)
  • Roche Group Sales by Segment (2020)
  • Roche Group Sales by Region (2020)
  • Medtronic Net Sales and Net Income (2017-2021)
  • Medtronic Net Sales by Segment (2021)
  • Medtronic Net Sales by Region (2020)
  • Qiagen Net Sales and Net Income (Loss) (2016-2020)
  • Qiagen Net Sales by Segment (2020)
  • Qiagen Net Sales by Region (2020)

List of Tables

  • Key Players - Revenue Comparison (2020/21)
  • Key Players - Market Capitalization Comparison (2021)
  • Key Players - Research & Development Expenses Comparison (2020/21)